Risk Factors for Disease Progression and Clinical Outcomes in Patients with COVID-19 in Taiwan: a Nationwide Population-based Cohort Study

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Date 2025 Jan 26

PMID 39865259

Authors

Raymond N Kuo

Wanchi Chen

Wen-Yi Shau

Affiliations

Soon will be listed here.

Abstract

Background: Since 2021, COVID-19 has had a substantial impact on global health and continues to contribute to serious health outcomes. In Taiwan, most research has focused on hospitalized patients or mortality cases, leaving important gaps in understanding the broader effects of the disease and identifying individuals at high risk. This study aims to investigate the risk factors for disease progression through a nationwide population-based cohort study on COVID-19 in Taiwan.

Methods: This study included 15,056 patients diagnosed with COVID-19 between January 1, 2021, and December 31, 2021, using the Taiwan National Health Insurance Research Database. Baseline and clinical characteristics were collected to verify the association with progression to severity outcomes, including hospital admission, intensive care unit (ICU) admission, invasive ventilatory support, fatal outcome, and the composite outcome of these four events. Patients were observed for 30 days for disease progression. Multivariable logistic regression models were used to calculate odd ratios and 95% confidence intervals (CIs) for each outcome, adjusting for age, sex, region, risk factors, and vaccination status.

Results: Overall, 8,169 patients diagnosed during outpatient visits and 6,887 patients diagnosed during hospitalization were analyzed. Adjusting for age, sex, region, risk factors, and vaccination status, elderly patients had higher risks of hospital admission, ICU admission, invasive ventilatory support, fatal outcome, and composite outcome. Specifically, the risk of the fatal outcome was significantly higher for patients aged 75-84 (odds ratio: 6.11, 95% CI: 4.75-7.87) and those aged 85 years and older (12.70, 9.48-17.02). Patients with cardiovascular disease exhibited higher risks of hospital admission (1.60, 1.31-1.96), ICU admission (1.52, 1.31-1.78), invasive ventilatory support (1.57, 1.26-1.96), and fatal outcomes (1.26, 1.03-1.54) and the composite outcome (1.66, 1.20-1.54). Diabetes mellitus was identified as a significant risk factor for all clinical outcomes (hospital admission: 1.89, 1.53-2.35; ICU admission: 1.53, 1.30-1.79; invasive ventilatory support: 1.27, 1.01-1.60; the composite outcome: 1.45, 1.28-1.66), except for the fatal outcome.

Conclusions: This study indicated the impact of sex, age, and risk factors on the clinical outcomes of COVID-19 patients in Taiwan. Elderly patients and those with cardiovascular disease or diabetes mellitus had higher risks for severe outcomes, including hospitalization, ICU admission, invasive ventilatory support, and mortality. These findings can provide evidence for a better understanding of risk factors for disease progression and inform targeted intervention.

References

Lai C, Lee P, Hsueh P . How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020-2022. J Microbiol Immunol Infect. 2023; 56(3):433-441. PMC: 10079311. DOI: 10.1016/j.jmii.2023.04.001. View

Huang A, Lin S, Chiu T, Chang K, Huang T, Yang T . Comparison of Clinical Characteristics and Outcomes of Hospitalized Patients Infected with the D614G Strain or Alpha Variant of COVID-19 in Taiwan: A Multi-Center Cohort Study. Int J Med Sci. 2022; 19(13):1912-1919. PMC: 9682515. DOI: 10.7150/ijms.76725. View

Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S . Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19. JAMA Netw Open. 2020; 3(12):e2029058. PMC: 7729428. DOI: 10.1001/jamanetworkopen.2020.29058. View

Yan Y, Ho S, Chien T, Chou W . Assessing the impact of COVID-19 on outpatient and inpatient revenues: A comparative analysis of large and small hospitals in Taiwan. Medicine (Baltimore). 2023; 102(45):e35787. PMC: 10637565. DOI: 10.1097/MD.0000000000035787. View

Driggin E, Madhavan M, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G . Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75(18):2352-2371. PMC: 7198856. DOI: 10.1016/j.jacc.2020.03.031. View

Wynants L, Van Calster B, Collins G, Riley R, Heinze G, Schuit E . Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020; 369:m1328. PMC: 7222643. DOI: 10.1136/bmj.m1328. View

Sheng W, Hsieh S, Chang S . Achievements of COVID-19 vaccination programs: Taiwanese perspective. J Formos Med Assoc. 2023; 123 Suppl 1:S70-S76. PMC: 10133881. DOI: 10.1016/j.jfma.2023.04.017. View

Cummings M, Baldwin M, Abrams D, Jacobson S, Meyer B, Balough E . Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020; 395(10239):1763-1770. PMC: 7237188. DOI: 10.1016/S0140-6736(20)31189-2. View

Binns C, Lee M, Doan T, Lee A, Pham M, Zhao Y . COVID and Gender: A Narrative Review of the Asia-Pacific Region. Int J Environ Res Public Health. 2023; 20(1). PMC: 9819659. DOI: 10.3390/ijerph20010245. View

10.

Izcovich A, Ragusa M, Tortosa F, Marzio M, Agnoletti C, Bengolea A . Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020; 15(11):e0241955. PMC: 7671522. DOI: 10.1371/journal.pone.0241955. View

11.

Chen C, Cheng-Chung Wei J . Employing digital technologies for effective governance: Taiwan's experience in COVID-19 prevention. Health Policy Technol. 2023; 12(2):100755. PMC: 10149355. DOI: 10.1016/j.hlpt.2023.100755. View

12.

Cheng H, Liu D . Early Prompt Response to COVID-19 in Taiwan: Comprehensive surveillance, decisive border control, and information technology support. J Formos Med Assoc. 2022; 123 Suppl 1:S2-S7. PMC: 9650562. DOI: 10.1016/j.jfma.2022.11.002. View

13.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y . Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1):110-118. PMC: 7152876. DOI: 10.1016/j.jaci.2020.04.006. View

14.

Lin S, Huang A, Chiu T, Chang K, Huang T, Yang T . Clinical and laboratory predictors for disease progression in patients with COVID-19: A multi-center cohort study. Biomed J. 2022; 46(1):100-109. PMC: 9674567. DOI: 10.1016/j.bj.2022.11.002. View

15.

Chiang W, Chen S . Time attitudes affecting psychological health during COVID-19 pandemic: a two-wave, six-month prospective study in Taiwan. Curr Psychol. 2023; :1-13. PMC: 10131497. DOI: 10.1007/s12144-023-04643-9. View

16.

Lin Y, Yen C, Chang Y, Wang P . Comparisons of Motivation to Receive COVID-19 Vaccination and Related Factors between Frontline Physicians and Nurses and the Public in Taiwan: Applying the Extended Protection Motivation Theory. Vaccines (Basel). 2021; 9(5). PMC: 8160641. DOI: 10.3390/vaccines9050528. View

17.

Matsushita K, Ding N, Kou M, Hu X, Chen M, Gao Y . The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis. Glob Heart. 2020; 15(1):64. PMC: 7546112. DOI: 10.5334/gh.814. View

18.

Wu H, Su C, Chien L, Tseng S, Chang S . Healthcare-associated COVID-19 outbreaks: a nationwide population-based cohort study. J Hosp Infect. 2022; 124:29-36. PMC: 8907114. DOI: 10.1016/j.jhin.2022.02.023. View

19.

Lin L, Warren-Gash C, Smeeth L, Chen P . Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2019; 40:e2018062. PMC: 6367203. DOI: 10.4178/epih.e2018062. View

20.

Peckham H, de Gruijter N, Raine C, Radziszewska A, Ciurtin C, Wedderburn L . Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020; 11(1):6317. PMC: 7726563. DOI: 10.1038/s41467-020-19741-6. View